Release Date: 01/12/16 08:36 Summary: Net Tangible Asset Backing Price Sensitive: No Download Document 436.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%